Overview

Anticoagulant Plus Antiplatelet Therapy Following Iliac Vein Stenting

Status:
Not yet recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of combination of anticoagulant and antiplatelet therapy on the patency of iliac vein at 12-month post stenting in patients with acute proximal DVT and ipsilateral iliac vein stenosis who received percutaneous mechanic thrombectomy and iliac vein stenting.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital of Zhejiang University
Collaborators:
Affiliated Hangzhou First People's Hospital, School of Medicine, Zhejiang University
Boston Scientific Corporation
Ningbo No.2 Hospital
Taizhou Enze Hospital
Taizhou First People's Hospital
Taizhou Hospital of Zhejiang Province
The Central Hospital of Lishui City
Zhejiang University
Treatments:
Anticoagulants
Aspirin
Rivaroxaban